IP Library › Granted Patent US 9,796,795
Granted Patent B2
US 9,796,795 · App. 15/145,314 · Granted Oct 24, 2017

Tetrahydroindacenyl catalyst composition, catalyst system, and processes for use thereof

Inventors: Jo Ann M. Canich (Houston, TX); Crisita Carmen H. Atienza (Houston, TX); Vyatcheslav V. Izmer (Moscow, RU); Dmitry S. Kononovich (Moscow, RU); Alexander Z. Voskoboynikov (Moscow, RU)
Assignee: ExxonMobil Chemical Patents Inc.
C08F4/76C07F7/28C07F17/00C08F4/6592C08F4/65912C08F110/02C08F110/06C08F210/02C08F4/65908C08F2420/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,796,795
App. No.
15/145,314
Granted
Oct 24, 2017
Kind
B2
Abstract

This invention relates to a compound represented by the formula: T y Cp′ m MG n X q wherein: Cp′ is a tetrahydroindacenyl group which may be substituted or unsubstituted, provided that when Cp′ is tetrahydro-s-indacenyl: 1) the 3 and/or 4 positions are not aryl or substituted aryl, 2) the 3 position is not directly bonded to a group 15 or 16 heteroatom, 3) there are no additional rings fused to the tetrahydroindacenyl ligand, 4) T is not bonded to the 2-position, and 5) the 5, 6, or 7-position is geminally disubstituted; M is a group 3, 4, 5, or 6 transition metal; G is a heteroatom group represented by the formula JR i z where J is N, P, O or S, R i is a C 1 to C 20 hydrocarbyl group, and z is 1 or 2; T is a bridging group; y is 0 or 1; X is a leaving group; m=1; n=1, 2 or 3; q=1, 2 or 3, and the sum of m+n+q is equal to the oxidation state of the transition metal.

Claims (101)

1. A compound represented by the formula: T y Cp′ m MG n X q

wherein: Cp′ is a tetrahydroindacenyl group which is optionally substituted or unsubstituted, provided that when Cp′ is tetrahydro-s-indacenyl: 1) the 3 and/or 4 positions are not aryl or substituted aryl, 2) the 3 position is not directly bonded to a group 15 or 16 heteroatom, 3) there are no additional rings fused to the tetrahydroindacenyl ligand, 4) T is not bonded to the 2-position, and 5) the 5, 6, or 7-position is geminally disubstituted;

M is a group 3, 4, 5, or 6 transition metal;

G is a heteroatom group represented by the formula JR i z where J is N, P, O or S, R i is a C 1 to C 20 hydrocarbyl group, and z is 1 or 2;

T is a bridging group;

y is 0 or 1;

X is a leaving group;

m=1;

n=1, 2 or 3;

q=1, 2 or 3; and

the sum of m+n+q is equal to the oxidation state of the transition metal.

2. A compound represented by the formula (I):

where:

M is a group 4 metal;

J is N, O, S or P;

p is 1 when J is N or P, and is 0 when J is O or S;

each R a is independently a C 1 -C 10 alkyl;

each R c is independently hydrogen or a C 1 -C 10 alkyl;

R 2 , R 3 , R 4 , and R 7 are independently hydrogen, or a C 1 -C 50 substituted or unsubstituted hydrocarbyl, halocarbyl or silylcarbyl, provided that: 1) R 3 and/or R 4 are not aryl or substituted aryl, 2) R 3 is not substituted with a group 15 or 16 heteroatom; and 3) that adjacent R 4 , R c , R a , and or R 7 do not join together to form a fused ring system;

each R′ is independently a C 1 -C 100 substituted or unsubstituted hydrocarbyl, halocarbyl, or silylcarbyl;

T is (CR 8 R 9 ) x , SiR 8 R 9 or GeR 8 R 9 where x is 1 or 2, R 8 and R 9 are independently selected from hydrogen, or substituted or unsubstituted hydrocarbyl, halocarbyl, silylcarbyl and germylcarbyl and R 8 and R 9 are optionally bonded together to form a ring structure;

each X is, independently, a leaving group, or two Xs are joined and bound to the metal atom to form a metallocycle ring, or two Xs are joined to form a chelating ligand, a diene ligand, or an alkylidene.

3. A compound represented by the formula (III):

where M is group 3, 4, 5, or 6 transition metal;

B is the oxidation state of M, and is 3, 4, 5 or 6;

c is B-2;

J is N, O, S or P;

p is 1 when J is N or P, and is 0 when J is O or S;

R 2 , R 3 , R 6 , and R 7 , are independently hydrogen, or a C 1 -C 50 substituted or unsubstituted hydrocarbyl, halocarbyl or silylcarbyl;

each R b and R c is independently C 1 -C 10 alkyl, or hydrogen;

each R′ is, independently, a C 1 -C 100 substituted or unsubstituted hydrocarbyl, halocarbyl, silylcarbyl or germycarbyl;

T is (CR 8 R 9 ) x , SiR 8 R 9 or GeR 8 R 9 where x is 1 or 2, R 8 and R 9 are independently selected from hydrogen, substituted or unsubstituted hydrocarbyl, halocarbyl, silylcarbyl and germylcarbyl, and R 8 and R 9 may optionally be bonded together to form a ring structure;

each X is, independently, a leaving group, or two Xs are joined and bound to the metal atom to form a metallocycle ring, or two Xs are joined to form a chelating ligand, a diene ligand, or an alkylidene.

4. The catalyst compound of claim 1 , wherein M is Ti.

5. The compound of claim 1 , where J is N, and R′ is methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, cyclooctyl, cyclododecyl, decyl, undecyl, dodecyl, adamantyl or an isomer thereof.

6. The catalyst compound of claim 2 wherein R 2 , R 3 , R 4 , and/or R 7 , are not aryl or substituted aryl.

7. The catalyst compound of claim 3 , wherein R 2 , R 3 , R 6 , and/or R 7 , are not aryl or substituted aryl.

8. The compound of claim 2 , wherein each R a is independently selected from the group consisting of methyl, ethyl, propyl, butyl, pentyl, hexyl and isomers thereof.

9. The compound of claim 1 , wherein the sum of m+n+q is equal to 3, 4, 5, or 6.

10. The compound of claim 1 , wherein the Cp′ is tetrahydro-s-indacenyl and the 6 position is geminally disubstituted with two C 1 -C 10 alkyl groups.

11. The compound of claim 1 , wherein the Cp′ is tetrahydro-s-indacenyl and the 6 position is geminally disubstituted with two alkyl groups selected from the group consisting of methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, and dodecyl and isomers thereof.

12. The compound of claim 1 , wherein the Cp′ is tetrahydro-s-indacenyl and the 3 and 4 positions are not aryl or substituted aryl.

13. The compound of claim 3 , wherein each R b is independently a C 1 -C 10 alkyl.

14. The compound of claim 1 , where J is N, and R i is t-butyl, hexyl, neopentyl, cyclohexyl, cyclooctyl, cyclododecyl, adamantyl, or norbornyl.

15. A composition comprising one or more of:

dimethylsilylene(2,6,6-trimethyl-1,5,6,7-tetrahydro-s-indacen-1-yl)(cyclododecylamido)M(R) 2 ;

dimethylsilylene(2,6,6-trimethyl-1,5,6,7-tetrahydro-s-indacen-1-yl)(t-butylamido)M(R) 2 ;

dimethylsilylene(6,6-dimethyl-1,5,6,7-tetrahydro-s-indacen-1-yl)(cyclododecylamido)M(R) 2 ;

dimethylsilylene (6,6-dimethyl-1,5,6,7-tetrahydro-s-indacen-1-yl)(t-butylamido)M(R) 2 ;

dimethylsilylene(2,7,7-trimethyl-3,6,7,8-tetrahydro-as-indacen-3-yl)(cyclododecylamido)M(R) 2 ;

dimethylsilylene(2,7,7-trimethyl-3,6,7,8-tetrahydro-as-indacen-3-yl)(t-butylamido)M(R) 2 ,

dimethylsilylene(7,7-dimethyl-3,6,7,8-tetrahydro-as-indacen-3-yl)(cyclododecylamido)M(R) 2 ;

dimethylsilylene(7,7-dimethyl-3,6,7,8-tetrahydro-as-indacen-3-yl)(t-butylamido)M(R) 2 ;

μ-(CH 3 ) 2 Si(2,6,6-trimethyl-1,5,6,7-tetrahydro-s-indacen-1-yl)(1-adamantylamido)M(R) 2 ;

μ-(CH 3 ) 2 Si(6,6-dimethyl-1,5,6,7-tetrahydro-s-indacen-1-yl)(1-adamantylamido)M(R) 2 ;

μ-(CH 3 ) 2 Si(2-methyl-6,6-diethyl-1,5,6,7-tetrahydro-s-indacen-1-yl)(1-adamantylamido)M(R) 2 ;

μ-(CH 3 ) 2 Si(6,6-diethyl-1,5,6,7-tetrahydro-s-indacen-1-yl)(1-adamantylamido)M(R) 2 ;

μ-(CH 3 ) 2 Si(2,7,7-trimethyl-3,6,7,8-tetrahydro-as-indacen-3-yl)(1-adamantylamido)M(R) 2 ;

μ-(CH 3 ) 2 Si(7,7-dimethyl-3,6,7,8-tetrahydro-as-indacen-3-yl)(1-adamantylamido)M(R) 2 ;

μ-(CH 3 ) 2 Si(2-methyl-3,6,7,8-tetrahydro-as-indacen-3-yl)(1-adamantylamido)M(R) 2 ;

μ-(CH 3 ) 2 Si(2-methyl-7,7-diethyl-3,6,7,8-tetrahydro-as-indacen-3-yl)(1-adamantylamido)M(R) 2 ;

μ-(CH 3 ) 2 Si(7,7-diethyl-3,6,7,8-tetrahydro-as-indacen-3-yl)(1-adamantylamido)M(R) 2 ;

μ-(CH 3 ) 2 Si(2,6,6-trimethyl-1,5,6,7-tetrahydro-s-indacen-1-yl)(t-butylamido)M(R) 2 ;

μ-(CH 3 ) 2 Si(6,6-dimethyl-1,5,6,7-tetrahydro-s-indacen-1-yl)(t-butylamido)M(R) 2 ;

μ-(CH 3 ) 2 Si(2-methyl-6,6-diethyl-1,5,6,7-tetrahydro-s-indacen-1-yl)(t-butylamido)M(R) 2 ;

μ-(CH 3 ) 2 Si(6,6-diethyl-1,5,6,7-tetrahydro-s-indacen-1-yl)(t-butylamido)M(R) 2 ;

μ-(CH 3 ) 2 Si(2,7,7-trimethyl-3,6,7,8-tetrahydro-as-indacen-3-yl)(t-butylamido)M(R) 2 ;

μ-(CH 3 ) 2 Si(7,7-dimethyl-3,6,7,8-tetrahydro-as-indacen-3-yl)(t-butylamido)M(R) 2 ;

μ-(CH 3 ) 2 Si(2-methyl-3,6,7,8-tetrahydro-as-indacen-3-yl)(t-butylamido)M(R) 2 ;

μ-(CH 3 ) 2 Si(2-methyl-7,7-diethyl-3,6,7,8-tetrahydro-as-indacen-3-yl)(t-butylamido)M(R) 2 ;

μ-(CH 3 ) 2 Si(7,7-diethyl-3,6,7,8-tetrahydro-as-indacen-3-yl)(t-butylamido)M(R) 2 ;

μ-(CH 3 ) 2 Si(2,6,6-trimethyl-1,5,6,7-tetrahydro-s-indacen-1-yl)(cyclododecylamido)M(R) 2 ;

μ-(CH 3 ) 2 Si(6,6-dimethyl-1,5,6,7-tetrahydro-s-indacen-1-yl)(cyclododecylamido)M(R) 2 ;

μ-(CH 3 ) 2 Si(2-methyl-6,6-diethyl-1,5,6,7-tetrahydro-s-indacen-1-yl)(cyclododecylamido)M(R) 2 ;

μ-(CH 3 ) 2 Si(6,6-diethyl-1,5,6,7-tetrahydro-s-indacen-1-yl)(cyclododecylamido)M(R) 2 ;

μ-(CH 3 ) 2 Si(2,7,7-trimethyl-3,6,7,8-tetrahydro-as-indacen-3-yl)(cyclododecylamido)M(R) 2 ;

μ-(CH 3 ) 2 Si(7,7-dimethyl-3,6,7,8-tetrahydro-as-indacen-3-yl)(cyclododecylamido)M(R) 2 ;

μ-(CH 3 ) 2 Si(2-methyl-3,6,7,8-tetrahydro-as-indacen-3-yl)(cyclododecylamido)M(R) 2 ;

μ-(CH 3 ) 2 Si(2-methyl-7,7-diethyl-3,6,7,8-tetrahydro-as-indacen-3-yl)(cyclododecylamido)M(R) 2 ;

μ-(CH 3 ) 2 Si(7,7-diethyl-3,6,7,8-tetrahydro-as-indacen-3-yl)(cyclododecylamido)M(R) 2 ;

μ-(CH 2 ) 3 Si(2,6,6-trimethyl-1,5,6,7-tetrahydro-s-indacen-1-yl)(t-butylamido)M(R) 2 ;

μ-(CH 2 ) 4 Si(2,6,6-trimethyl-1,5,6,7-tetrahydro-s-indacen-1-yl)(t-butylamido)M(R) 2 ;

μ-(CH 2 ) 5 Si(2,6,6-trimethyl-1,5,6,7-tetrahydro-s-indacen-1-yl)(t-butylamido)M(R) 2 ;

μ-(CH 3 ) 2 C(2,6,6-trimethyl-1,5,6,7-tetrahydro-s-indacen-1-yl)(t-butylamido)M(R) 2 ;

μ-(CH 2 ) 3 Si(2,6,6-trimethyl-1,5,6,7-tetrahydro-s-indacen-1-yl)(t-butylamido)M(R) 2 ;

μ-(CH 2 ) 4 Si(2,6,6-trimethyl-1,5,6,7-tetrahydro-s-indacen-1-yl)(t-butylamido)M(R) 2 ;

μ-(CH 2 ) 5 Si(2,6,6-trimethyl-1,5,6,7-tetrahydro-s-indacen-1-yl)(t-butylamido)M(R) 2 ;

μ-(CH 3 ) 2 C(2,6,6-trimethyl-1,5,6,7-tetrahydro-s-indacen-1-yl)(t-butylamido)M(R) 2 ; and

μ-(CH 3 ) 2 Si(2,6,6-trimethyl-1,5,6,7-tetrahydro-s-indacen-1-yl)(neopentylamido)M(R) 2 ;

where M is selected from a group consisting of Ti, Zr, and Hf and R is selected from halogen and C 1 to C 5 alkyl.

16. The compound of claim 3 , wherein the compound is represented by the formula:

where M, B, c, J, p, R 2 , R 3 , R 6 , R 7 , R′, T, y and X are as defined in claim 3 and each R b , R c , and R d is independently C 1 -C 10 alkyl, or hydrogen, provided that both R b , both R c , or both R d are not hydrogen.

17. A catalyst system comprising the compound of claim 1 and an activator.

18. The catalyst system of claim 17 , wherein the activator comprises a non-coordinating anion activator and/or an alumoxane.

19. The catalyst system of claim 17 , where the catalyst system is supported.

20. A process to produce olefin polymer comprising contacting olefin monomer with the catalyst system of claim 17 .

21. The process of claim 20 , wherein the monomer comprises ethylene and/or propylene.

22. The process of claim 20 , wherein the catalyst system comprises one catalyst compound.

23. The process of claim 20 , wherein the process occurs at a temperature of from about 0° C. to about 300° C., at a pressure in the range of from about 0.35 MPa to about 16 MPa, and at a time up to 300 minutes.

24. The process of claim 20 , wherein the monomer comprises two or more of ethylene, propylene, butene, pentene, hexene, heptene, octene, nonene, decene, undecene, or dodecene.

25. The process of claim 20 , wherein the monomer comprises ethylene, propylene and 5-ethylidene-2-norbornene.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 18, 2016
From: CANICH, JO ANN M.; ATIENZA, CRISITA CARMEN H.; IZMER, VYATCHESLAV V.; KONONOVICH, DMITRY S.; VOSKOBOYNIKOV, ALEXANDER Z.
To: EXXONMOBIL CHEMICAL PATENTS INC.
Reel/Frame 038638/0254 →
Continuity (9)
Continuation In Part PCTUS2015067582 · Dec 28, 2015
Continuation In Part PCTUS2015067586 · Dec 28, 2015
Continuation In Part PCTUS2015067587 · Dec 28, 2015
Continuation In Part PCTUS2016021751 · Mar 10, 2016
Continuation In Part PCTUS2016021748 · Mar 10, 2016
Provisional Application 62103372 · Jan 14, 2015
Provisional Application 62149799 · Apr 20, 2015
Provisional Application 62149814 · Apr 20, 2015
Related Publication 20160244535A1 · Aug 25, 2016